This program will address various legal, regulatory, and policy hurdles for health care businesses that venture into social media advertising and marketing, including relationships between health care providers and social media influencers. Nixon Peabody’s national health care and entertainment team will address key issues facing innovative digital health companies and traditional health care providers when engaging in online and social media marketing.
Our discussion will cover:
• fraud and abuse restrictions on referrals, including the federal Anti-Kickback Statute and the Stark Law;
• truth-in-advertising laws, including guidance from the Federal Trade Commission;
• state laws impacting advertising of physician services;
• evolving policies from social media companies, including Facebook’s recent changes to its policies around prescription drug advertising for online pharmacies, telehealth providers, and pharmaceutical manufacturers; and
• key considerations for content creators and influencers using these platforms to market health care services and products.
What are the left and rights limits, penalties, and best practices for export controls under Interna...
Effective representation depends on trust, communication, and responsiveness, yet these can break do...
There are countless trial skill CLEs that will teach you the basics of trial strategies. This CLE is...
During this course, you will learn about best practices and strategies for retaining intellectual pr...
State attorneys general continue to play a central and increasingly aggressive role in consumer prot...
Most legal professionals are operating in survival mode whether they realize it or not. Not crisis-l...
This program provides attorneys with a practical examination of how legal, regulatory, and liability...
Adverse and derogatory information often has devastating effects on a contractor's ability to win co...
Class action litigation continues to evolve rapidly in response to an innovative plaintiffs’ b...
This presentation serves as a critical follow-up to the June 12, 2026, session on PTAB Discretionary...